Molecules 2010, 15
539
(1S)-1-[(1R)-2-Nitro-1-phenylethyl]-2-oxo-cyclopentanecarboxylic Acid Methyl Ester (5aa) [34,35,37].
1
5aa is a known compound. colorless oil; IR (neat) ν 2956, 1751, 1725, 1552, 1230, 1149 cm−1; H
NMR (CDCl3) δ 1.76–2.06 (m, 4H), 2.30–2.40 (m, 2H), 3.74 (s, 3H), 4.06 (dd, J = 4.0, 11.0 Hz, 1H),
13
4.99 (dd, J = 11.0, 13.8 Hz, 1H), 5.14 (dd, J = 4.0, 13.8 Hz, 1H) , 7.20–7.32 (m, 5H); C NMR
(CDCl3) δ 19.3, 31.0, 37.9, 46.1, 53.0, 62.4, 76.3, 128.3, 128.8, 129.2, 135.2, 169.7, 212.2; ESI-MS
m/z 314 [M+Na]+; [α]D21.0 +41.7 (c 0.844, CHCl3); HPLC (DAICEL CHIRALCEL OD, hexane/2-
propanol = 90/10, flow 1.0 mL/min, detection at 220 nm) tR 14.8 min (major) and 21.5 min (minor).
Relative configuration of 5aa was determined by comparing the 1H-NMR and 13C-NMR data with the
reported data. Absolute configuration of 5aa was determined by comparison of the sign of optical
rotation with the reported data. Lit. [α]D25 + 36.5 (c, 0.84, CHCl3) [34,35].
(1S)-1-[(1R)-1-(4-Chlorophenyl)-2-nitroethyl]-2-oxo-cyclopentanecarboxylic Acid Methyl Ester
1
(5ba) [37]. Colorless solid; IR (KBr) ν 2960, 1724, 1554, 1218 cm−1; H-NMR (CDCl3) δ 1.76–1.95
(m, 3H), 1.97–2.08 (m, 1H), 2.28–2.40 (m, 2H), 3.71 (s, 3H), 4.00 (dd, J = 4.0, 11.0 Hz, 1H), 4.93
(dd, J = 11.0, 13.7 Hz, 1H), 5.11 (dd, J = 4.0, 13.7 Hz, 1H), 7.15–7.20 (m, 2H), 7.22–7.27 (m, 2H); 13C
NMR (CDCl3) δ 19.2, 31.2, 37.8, 45.5, 53.0, 62.1, 76.1, 128.9, 130.6, 133.8, 134.2, 169.6, 212.1;
ESI-MS m/z 348, 350 [M+Na]+; HRMS calcd. for C15H16ClNO5Cs [M+Cs]+: 457.9771, found
457.9763; [α]D25.6 +42.6 (c 1.05, CHCl3); HPLC (DAICEL CHIRALCEL OD, hexane/2-propanol = 90/10,
flow 1.0 mL/min, detection at 220 nm) tR 20.3 min (major) and 34.5 min (minor).
(1S)-1-[(1R)-1-(4-Bromophenyl)-2-nitroethyl]-2-oxo-cyclopentanecarboxylic Acid Methyl Ester (5ca).
1
Colorless solid; IR (KBr) ν 2958, 1756, 1720, 1552, 1232, 1155 cm−1; H-NMR (CDCl3) δ 1.77–1.99
(m, 3H), 2.00–2.12 (m, 1H), 2.31–2.42 (m, 2H), 3.73 (s, 3H), 4.00 (dd, J = 4.0, 11.5 Hz, 1H), 4.95 (dd,
J = 11.5, 14.4 Hz, 1H), 5.12 (dd, J = 4.0, 13.4 Hz, 1H), 7.12–7.16 (m, 2H), 7.40–7.44 (m, 2H);
13C-NMR (CDCl3) δ 19.2, 31.1, 37.7, 45.5, 52.9, 62.0, 76.0, 122.3, 130.9, 131.8, 134.2, 169.5, 212.0;
ESI-MS m/z 392, 394 [M+Na]+; HRMS calcd. for C15H16BrNO5Cs [M+Cs]+: 501.9266, found
501.9274; [α]D25.6 +40.2 (c 1.08, CHCl3); HPLC (DAICEL CHIRALCEL OD, hexane/2-propanol = 90/10,
flow 1.0 mL/min, detection at 220 nm) tR 25.0 min (major) and 37.6 min (minor).
(1S)-1-[(1R)-1-(3-Bromophenyl)-2-nitroethyl]-2-oxo-cyclopentanecarboxylic Acid Methyl Ester (5da).
1
Colorless oil; IR (neat) ν 2922, 1751, 1726, 1554, 1230, 1147 cm−1; H-NMR (CDCl3) δ 1.82–1.98
(m, 3H), 2.08–2.17 (m, 1H), 2.31–2.44 (m, 2H), 3.74 (s, 3H), 3.94 (dd, J = 4.0, 11.0 Hz, 1H), 4.97 (dd,
J = 11.0, 13.7 Hz, 1H), 5.17 (dd, J = 3.7, 13.7 Hz, 1H), 7.15–7.21 (m, 2H), 7.39–7.43 (m, 2H);
13C-NMR (CDCl3) δ 19.2, 31.5, 37.7, 45.7, 53.0, 62.0, 76.0, 122.7, 128.0, 130.2, 131.4, 132.2, 137.7,
169.6, 212.0; ESI-MS m/z 392, 394 [M+Na]+; HRMS calcd. for C15H16BrNO5Cs [M+Cs]+: 501.9266,
25.6
found 501.9272; [α]D
+13.1 (c 0.993, CHCl3); HPLC (DAICEL CHIRALCEL OD, hexane/2-
propanol = 90/10, flow 1.0 mL/min, detection at 220 nm) tR 21.7 min (major) and 27.2 min (minor).
(1S)-1-[(1S)-1-(2-Bromophenyl)-2-nitroethyl]-2-oxo-cyclopentanecarboxylic Acid Methyl Ester (5ea) [37].
1
Yellow solid; IR (KBr) ν 2960, 1724, 1554, 1242 cm−1; H-NMR (CDCl3) δ 1.85–1.98 (m, 2H),
2.04–2.15 (m, 1H), 2.16–2.24 (m, 1H), 2.44–2.50 (m, 2H), 3.72 (s, 3H), 4.48 (dd, J = 3.5, 10.7 Hz, 1H),
5.03 (dd, J = 10.7, 13.7 Hz, 1H), 5.45 (dd, J = 3.5, 13.7 Hz, 1H), 7.11 (ddd, J = 1.5, 7.5, 8.0 Hz, 1H),
7.28 (ddd, J = 1.2, 7.5, 8.0 Hz, 1H), 7.49 (dd, J = 1.5, 8.0 Hz, 1H), 7.55 (dd, J = 1.2, 8.0 Hz, 1H);